ISIN | CH0356569118 |
---|---|
Valor Number | 35656911 |
Bloomberg Global ID | UBESPAW SW |
Fund Name | UBS (CH) Investment Fund - Equities Switzerland All Index A-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The fund invests in equities of major Swiss companies that are included in the SPI.|The fund holds all large and mid cap stocks in proportion to the free-float market capitalisation of the reference index. It invests in a selection of small cap stocks from the index according to the criteria of market liquidity and the sector’s free-float market capitalisation.|Diversification is achieved via a mix of sectors and therefore offers the investor an optimised risk/return profile.|The investment objective is to generate a performance in line with that of the benchmark, keeping the Tracking Error below the maximum of 0.5% over a rolling period of 3 years. |
Peculiarities |
Current Price * | 154.12 CHF | 04.04.2025 |
---|---|---|
Previous Price * | 162.18 CHF | 03.04.2025 |
52 Week High * | 172.02 CHF | 03.03.2025 |
52 Week Low * | 147.55 CHF | 16.04.2024 |
NAV * | 154.12 CHF | 04.04.2025 |
Issue Price * | 154.12 CHF | 04.04.2025 |
Redemption Price * | 154.12 CHF | 04.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 4,649,651,221 | |
Unit/Share Assets *** | 178,825,772 | |
Trading Information SIX |
YTD Performance | +0.46% |
31.12.2024 - 04.04.2025
31.12.2024 04.04.2025 |
---|---|---|
1 month | -9.36% |
04.03.2025 - 04.04.2025
04.03.2025 04.04.2025 |
3 months | -0.47% |
06.01.2025 - 04.04.2025
06.01.2025 04.04.2025 |
6 months | -3.09% |
04.10.2024 - 04.04.2025
04.10.2024 04.04.2025 |
1 year | +0.98% |
04.04.2024 - 04.04.2025
04.04.2024 04.04.2025 |
2 years | +6.95% |
04.04.2023 - 04.04.2025
04.04.2023 04.04.2025 |
3 years | -1.77% |
04.04.2022 - 04.04.2025
04.04.2022 04.04.2025 |
5 years | +33.71% |
06.04.2020 - 04.04.2025
06.04.2020 04.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 13.42% | |
---|---|---|
Roche Holding AG | 12.36% | |
Novartis AG Registered Shares | 11.74% | |
Compagnie Financiere Richemont SA Class A | 5.80% | |
UBS Group AG | 5.56% | |
Zurich Insurance Group AG | 5.11% | |
ABB Ltd | 4.53% | |
Holcim Ltd | 3.14% | |
Swiss Re AG | 2.49% | |
Alcon Inc | 2.45% | |
Last data update | 28.02.2025 |
TER | 0.17% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.30% |
Ongoing Charges *** | 0.13% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |